Intra-aortic balloon counterpulsation therapy

Kalpa De Silva, Divaka Perera

Research output: Contribution to journalReview article (Academic Journal)peer-review

1 Citation (Scopus)


Percutaneous coronary intervention in the presence of impaired left ventricular function is associated with significant mortality and morbidity. Intra-aortic balloon counterpulsation simultaneously increases coronary blood flow, by augmenting the diastolic aortocoronary pressure gradient, and decreases myocardial oxygen demand, by reducing the end-diastolic pressure, and therefore the afterload. This makes it an attractive means of ameliorating ischaemia and consequently enhancing cardiac output. Although contemporary randomized control trials have demonstrated that routine placement of an intra-aortic balloon pump (IABP) is not mandatory, a standby approach is recommended, as an important minority of patients require bail-out IABP insertion in the event of haemodynamic compromise. IABP therapy remains the safest and most readily available mechanical assist device to deploy in the catheter laboratory setting, with deployment guided by salient haemodynamics and the individual clinical scenario.

Original languageEnglish
Pages (from-to)580-581
Number of pages2
Issue number9
Early online date27 Jul 2018
Publication statusPublished - 1 Sep 2018


  • Coronary flow
  • diastolic augmentation
  • haemodynamics
  • intra-aortic balloon pump (IABP)
  • MRCP
  • percutaneous coronary intervention (PCI)
  • shock


Dive into the research topics of 'Intra-aortic balloon counterpulsation therapy'. Together they form a unique fingerprint.

Cite this